Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD) Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycyst ...
Phase II Study for the Second-Line Treatment of Hypertension in Patients With Autosomal Dominant Polycystic Kidney Disease; ACEI vs. CCB Phase II Study for the Second-Line Treatment of Hypertension in Patients With Autosomal Dominant Pol ...
CCB Safety Study in Treatment of Hypertension of ADPKD
Comparison Between ARB and ARB Plus CCB on Incidence of Renal and Cardiovascular Events in Hypertensive ADPKD Patients Comparison Between ARB and ARB Plus CCB on Incidence of Renal and Cardiovascular Events in Hypertens ...